全文获取类型
收费全文 | 1126篇 |
免费 | 52篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 43篇 |
妇产科学 | 14篇 |
基础医学 | 87篇 |
口腔科学 | 15篇 |
临床医学 | 230篇 |
内科学 | 127篇 |
皮肤病学 | 11篇 |
神经病学 | 34篇 |
特种医学 | 105篇 |
外科学 | 188篇 |
综合类 | 126篇 |
预防医学 | 64篇 |
眼科学 | 5篇 |
药学 | 32篇 |
肿瘤学 | 94篇 |
出版年
2022年 | 7篇 |
2021年 | 36篇 |
2018年 | 13篇 |
2015年 | 17篇 |
2014年 | 16篇 |
2013年 | 23篇 |
2012年 | 30篇 |
2011年 | 27篇 |
2010年 | 29篇 |
2009年 | 37篇 |
2008年 | 49篇 |
2007年 | 37篇 |
2006年 | 54篇 |
2005年 | 38篇 |
2004年 | 39篇 |
2003年 | 32篇 |
2002年 | 34篇 |
2001年 | 35篇 |
2000年 | 37篇 |
1999年 | 24篇 |
1998年 | 38篇 |
1997年 | 32篇 |
1996年 | 36篇 |
1995年 | 24篇 |
1994年 | 40篇 |
1993年 | 18篇 |
1992年 | 15篇 |
1991年 | 15篇 |
1990年 | 19篇 |
1989年 | 27篇 |
1988年 | 23篇 |
1987年 | 26篇 |
1986年 | 24篇 |
1985年 | 23篇 |
1984年 | 16篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 12篇 |
1980年 | 10篇 |
1979年 | 10篇 |
1978年 | 12篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1972年 | 15篇 |
1971年 | 8篇 |
1970年 | 9篇 |
1968年 | 6篇 |
排序方式: 共有1180条查询结果,搜索用时 31 毫秒
21.
Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy 总被引:7,自引:0,他引:7
J Boyages A Recht J L Connolly S J Schnitt R Gelman H Kooy S Love R T Osteen B Cady B Silver 《Radiotherapy and oncology》1990,19(1):29-41
The identification of factors associated with breast recurrence following conservative surgery (CS) and radiation therapy (RT) is of potential use in refining patient selection criteria and treatment technique. In an attempt to define such factors we examined the relationship between various clinical, pathologic and treatment characteristics and the likelihood of breast recurrence in 783 patients with clinical stage I or II breast cancer treated between July 1968 and December 1982. Treatment consisted of complete gross excision of the primary tumor and RT to a total dose of at least 60 Gy to the primary site. During this period, pre-treatment mammograms and detailed histologic assessment of the margins of resection were not routinely performed. Median follow-up for surviving patients was 80 months. Thirteen patients (1.6%) were lost to follow-up. Ninety-one patients (12%) have developed a breast recurrence, corresponding to 5- and 10-year actuarial rates of 10 and 18%, respectively. The major feature associated with breast recurrence was the presence of an "extensive intraductal component" (EIC+). An EIC+ tumor was seen in 28% of evaluable cases with infiltrating ductal carcinoma and accounted for 60% of breast recurrences. Forty-three of 166 patients (26%) with EIC+ tumors developed a breast recurrence compared with 29 of 418 patients (7%) without an EIC (EIC-) (p = 0.0001). The 5-year actuarial rates of breast relapse were 24 and 6%, respectively (p = 0.0001). Very young age (defined as 34 years of age or younger) was also a significant factor associated with the risk of breast recurrence. Very young patients comprised 8% of the patient population and accounted for 16% of breast recurrences. Fifteen of 61 very young patients (25%) developed a breast recurrence compared with 76 of 722 older patients (11%) (p = 0.001). The corresponding 5-year actuarial rates of breast recurrence were 21 and 9% (p = 0.005). None of the other clinical or pathological factors examined by univariate analysis were significantly correlated with recurrence in the breast. A multivariate model of site of first failure (polychotomous logistic regression) also showed that EIC+ tumors and very young age were the main factors associated with a high relative risk of breast recurrence. We conclude that EIC+ tumors and very young age are associated with a high risk of breast recurrence for patients treated with limited excision prior to RT. 相似文献
22.
Renal transplant (RT) is now a therapy of choice for end stage renal disease (ESRD). The Nephrology Unit, Asvini started functioning in Dec 90 and to date 1298 sittings of hemodialysis have been given to 45 patients. Of these, 35 were in ESRD and 11 patients underwent renal transplantation at this hospital during the period Jan 91 – Dec 93. One patient expired after 18 months of transplantation due to infection. Early experience in screening patients for RT, use of immunosuppression, management of rejection episodes and protocol are presented with special emphasis on its relevance to the Armed Forces.KEY WORDS: Transplantation, Renal Failure, Immunosuppression, Rejection 相似文献
23.
Pediatric health screening procedures, both prenatal and postnatal, have a tremendous potential in improving the health status of children and in turn reducing the resource burden on the parents and the State. The existing recommendations, inherent problems and different screening procedures are discussed. The need for suitable mass screening pediatric procedures in the Indian context is stressed.KEY WORDS: Pediatric screening procedures 相似文献
24.
25.
26.
27.
The study compared elderly and young adults in their behavior and involvement in the decision making process of over-the-counter (OTC) medication purchases. Elderly subjects were more involved in the decision making process to purchase OTC medications compared to young adults. The elderly not only purchase and spend more money on medications but also read OTC labels completely. They requested help from the pharmacist more frequently than young adults. Needs of the elderly in making an OTC medication purchase were different compared to young adults. The two age groups differed on importance rating for several attributes regarding OTC medications, such as; ease of opening the package, child resistant package, side effects of medicine, manufacturer of medicine, print size on package labels, and greater choice of medicine. 相似文献
28.
29.
30.
Paul M. Busse M.D. Ph.D. Blake Cady M.D. Albert Bothe Jr. M.D. Roger Jenkins M.D. William V. McDermott M.D. Glenn Steele Jr. M.D. Ph.D. Michael D. Stone M.D. 《World journal of surgery》1991,15(3):352-356
The recognition of a high incidence of local failure following surgical management of adenocarcinoma of the gallbladder has led to the use of adjuvant radiation therapy. In order to deliver higher doses to the gallbladder bed, intraoperative radiation therapy (IORT) has been used both with and without external beam radiation.The experience to date is reviewed. Ten patients have been treated, all of whom had either gross residual or unresected disease. The median survival for the group was approximately 1 year. There were no long-term survivors. The IORT did not contribute to the overall morbidity.Because of the limited number of patients and the advanced nature of the disease, the role of IORT in the management of gallbladder carcinoma has yet to be determined. The utility of this modality will most likely reside in the treatment of minimal residual disease at the time of cholecystectomy rather than in the palliative treatment of unresectable tumors.
Resumen El reconocimiento de la elevada tasa de falla local en el tratamiento del adenocarcinoma de la vesícula biliar, ha motivado el uso de radioterapia adyuvante. Con el objeto de administrar altas dosis de irradiación al lecho de la vesícula billiar, se ha utilizado la radioterapia intraoperatoria (RTIO) con y sin irradiación externa.Se revisa la experiencia hasta la fecha. Diez pacientes han sido tratados, todos con enfermedad macroscópica residual o no resecable. La sobrevida media para el grupo fue de aproximadamente un año; no hay sobrevivientes a largo plazo. La RTIO no contribuyó a la morbilidad global.Debido al limitado número de pacientes y a lo avanzado de la enfermedad, el rol de la RTIO está aun por determinar. La utilidad de esta modalidad muy posiblemente habrá de residir en el tratamiento de enfermedad residual miima en el momento de la colecistectomiá, más qu en el tratamiento paliativo de tumores no resecables.
Résumé Reconnaître la fréquence importante des échecs locaux à la suite du traitement chirurgical de l'adénocarcinome de la vésicule a amené à ajouter la radiothérapie. Pour pouvoir donner des doses plus importantes au lit de la vésicule, l'irradiation peropératoire (IP) a été administrée à la fois avec et sans irradiation externe. L'expérience à ce jour a été passée en revue. Dix patients ont été traités qui avaient soit une grosse tumeur résiduelle soit un cancer non réséqué. La survie moyenne du groupe était d'un an à peu près. Il n'y a eu aucun survivant à long terme. L'IP n'a rien changé à la mortalité globale. Compte tenu du nombre limité des patients et de la nature avancée de la maladie, le rôle de l'IP dans le traitement du cancer de la vésicule reste à déterminer. La valeur de l'IP sera probablement de traiter la petite tumeur résiduelle au moment de la cholécystectomie plutôt que les tumeurs non résécables.相似文献